Kiniksa(KNSA) - 2025 Q3 - Earnings Call Transcript

Kiniksa Pharmaceuticals International (NasdaqGS:KNSA) Q3 2025 Earnings Call October 28, 2025 08:30 AM ET Company ParticipantsJohn Paolini - CMOMary Kate - Head of Art AdvisorySanj Patel - Chairman and CEOMark Ragosa - CFOJonathan Kirshenbaum - Associate Director of Investor RelationsRoss Moat - Chief Corporate and Commercial OfficerConference Call ParticipantsDavid Nierengarten - Senior Biotechnology Equity AnalystRoger Song - Senior Equity Research AnalystNick Larissa - Vice President and Biotech Equity Re ...